Antipyrine clearance and metabolite formation in children with congenital adrenal hyperplasia
- PMID: 4092001
- PMCID: PMC1400822
- DOI: 10.1111/j.1365-2125.1985.tb05134.x
Antipyrine clearance and metabolite formation in children with congenital adrenal hyperplasia
Abstract
Antipyrine salivary clearance and half-life and the rate of formation of three principal metabolites of antipyrine (4-hydroxyantipyrine, 3-hydroxymethylantipyrine and norantipyrine) were assessed in nine children with congenital adrenal hyperplasia, six of whom were salt-losers and three of whom were non-salt-losers. No differences were found in comparison with data obtained in normal children.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical